{"id":"W1991758119","doi":"10.1007/s00262-005-0010-0","title":"Monoclonal antibody therapy of chronic lymphocytic leukemia","year":2005,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Alemtuzumab; Chronic lymphocytic leukemia; Rituximab; Medicine; Fludarabine; Monoclonal antibody; Monoclonal antibody therapy; Immunology; Chemotherapy; Oncology; Leukemia; Antibody; Cancer research; Internal medicine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005211292,0.001322955,0.00547395,0.0009420359,0.0001644914,0.00003815969,0.001399317,0.001712053,0.003580092],"category_scores_gemma":[0.00004905596,0.001056105,0.001852303,0.001151093,0.001408376,0.0001508194,0.000213995,0.001551979,0.0003831686],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2014247,"about_ca_system_score_gemma":0.1890741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001793584,"about_ca_topic_score_gemma":0.00001661454,"domain_scores_codex":[0.9940795,0.0004217922,0.002074519,0.001209421,0.0007554824,0.001459283],"domain_scores_gemma":[0.9952759,0.0004804316,0.001180049,0.00252711,0.0003625905,0.0001739904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008605806,0.0001246274,0.000002421033,0.004587393,0.00609766,0.0001062939,0.0001370824,0.00002278654,0.001356513,0.0000830681,0.0005549865,0.9860666],"study_design_scores_gemma":[0.02276856,0.001110933,0.00001638238,0.01274526,0.000482246,0.001548749,0.00001321496,0.0002707029,0.0005128243,0.00001318616,0.9597375,0.0007804052],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00110347,0.9940185,0.00003812024,0.00004604763,0.00107688,0.00273166,0.0001119522,0.0002027698,0.0006706298],"genre_scores_gemma":[0.0001170867,0.9936287,0.0001565886,0.0002163182,0.001185039,0.0009736565,0.0004094337,0.0004304624,0.002882751],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9852862,"threshold_uncertainty_score":0.9999522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06360689097298267,"score_gpt":0.4219103626378996,"score_spread":0.3583034716649169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}